BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 28, 2018
View Archived Issues
Keeping leptin active
Read More
Hif-1 during high oxygen promotes tumor cell resistance
Read More
Discovery of a novel, orally available, transient receptor potential channel 6 inhibitor
Read More
Galecto Biotech compound is an orally available drug for fibrosis and cancer
Read More
Merck & Co. reports development of a full allosteric agonist of GPR40
Read More
BAY-1753011 provides vascular protection and decongestion without RAAS stimulation
Read More
Mutabilis SAS synthesizes prodrugs of beta-lactamase inhibitors
Read More
Shire Human Genetic Therapies patents TGF-beta inhibitors
Read More
Aryl hydrocarbon receptor antagonists discovered at Phenex Pharmaceuticals
Read More
FDA approves Imbruvica with rituximab for Waldenstrom's macroglobulinemia
Read More
Bristol-Myers Squibb presents novel Nav1.7 inhibitor for the treatment of pain
Read More
Sienna releases first-in-human study data on SNA-125 in psoriasis
Read More
Parasite protein protects mice from hemorrhagic cystitis by inducing IL-4 expression
Read More
Grant supports further investigation of NVP-015 for genetic mitochondrial diseases
Read More
FDA approves Xerava to treat complicated intra-abdominal infections
Read More
European Commission approves Mepsevii for non-neurological manifestations of MPS VII
Read More
LEO Pharma discovers novel JAK1 inhibitor with high clearance and low bioavailability
Read More
Sirtuin 6 is behind epigenetic melanoma drug resistance
Read More
FDA issues complete response letter for Waylivra NDA
Read More
Genfit completes enrollment in phase IIa trial of elafibranor for primary biliary cholangitis
Read More
Poxel completes enrollment in Japanese TIMES 3 trial of imeglimin in type 2 diabetes
Read More